Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocortisone plus Fludrocortisone vs Hydrocortisone in Septic Shock
NCT03710187Phase 2Completed
- Sponsor
- University of Tennessee Medical Center
- Start
- Nov 2018
- Primary completion
- Sep 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of fludrocortisone in septic shock, sponsored by University of Tennessee Medical Center. Started Nov 2018; status: completed.
02
Drugs
fludrocortisone
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT03710187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03710187.